The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Metabolic and Body Composition Factors in Subgroups of Obesity: What Do We Know?
Abstract
Obesity is thought to be a heterogeneous disorder with several possible etiologies; therefore, by examining subtypes of obesity we attempt to understand obesity’s heterogeneous nature. The purpose of this review was to investigate the roles of metabolic, body composition, and cardiovascular disease risk in subtypes of obesity. We briefly consider two subtypes of obesity that have been identified in the literature. One subset of individuals, termed the metabolically healthy, but obese (MHO), despite having large amounts of fat mass compared with at risk obese individuals shows a normal metabolic profile, but remarkably normal to high levels of insulin sensitivity. Preliminary evidence suggests that this could be due at least in part to lower visceral fat levels and earlier onset of obesity. A second subset, termed the metabolically obese, but normal weight (MONW), present with normal body mass index, but have significant risk factors for diabetes, metabolic syndrome, and cardiovascular disease, which could be due to higher fat mass and plasma triglycerides as well as higher visceral fat and liver content. We also briefly consider the potential role of adipose and gastrointestinal hormonal profiles in MHO and MONW individuals, which could lead to a better understanding of potential factors that may regulate their body composition. This information will eventually be invaluable in helping us understand factors that predispose to or protect obese individuals from metabolic and cardiovascular disease. Collectively, a greater understanding of the MHO and MONW individual has important implications for therapeutic decision making, the characterization of subjects in research protocols, and medical education.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity : Preventing and managing the global epidemic
Akram, D. S., Astrup, A. V., Atinmo, T., Boissin, J.-L., Bray, G. A., Carroll, K. N., Chitson, P., Chen, C., Dietz, W. H., Hill, J. O., et al. (2000) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 12,945
Circulating Ghrelin Levels Are Decreased in Human Obesity
Tschöp, M., Weyer, C., Tataranni, P. A., Devanarayan, V., Ravussin, E., & Heiman, M. L. (2001) · Diabetes · doi:10.2337/diabetes.50.4.707 · Cited by 2,008
New Criteria for `Obesity Disease' in Japan
The Examination Committee of Criter (2002) · Circulation Journal · doi:10.1253/circj.66.987 · Cited by 1,650
Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., & Mingrone, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119628 · Cited by 898
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome
Ferrannini, E., Haffner, S. M., Mitchell, B. D., & Stern, M. P. (1991) · Diabetologia · doi:10.1007/bf00403180 · Cited by 898
The metabolically obese, normal-weight individual revisited.
Ruderman, N., Chisholm, D., Pi-Sunyer, X., & Schneider, S. (1998) · Diabetes · doi:10.2337/diabetes.47.5.699 · Cited by 893
Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Targher, G., Alberiche, M., Bonadonna, R. C., & Muggeo, M. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1643 · Cited by 837
Zavaroni, I., Bonora, E., Pagliara, M., Dall'Aglio, E., Luchetti, L., Buonanno, G., Bonati, P. A., Bergonzani, M., Gnudi, L., Passeri, M., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201105 · Cited by 771
Adipose tissue as a buffer for daily lipid flux
Frayn, K. (2002) · Diabetologia · doi:10.1007/s00125-002-0873-y · Cited by 752
Havel, P. J. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200202000-00008 · Cited by 575
Cited by
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
Adipose Tissue, Inflammation, and Cardiovascular Disease
Berg, A. H., & Scherer, P. E. (2005) · Circulation Research · doi:10.1161/01.res.0000163635.62927.34 · Cited by 2,113
Obesity Stigma: Important Considerations for Public Health
Puhl, R. M., & Heuer, C. A. (2010) · American Journal of Public Health · doi:10.2105/ajph.2009.159491 · Cited by 1,917
Wildman, R. P. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1617 · Cited by 1,618
“who express cardiometabolic abnormalities often associated with being overweight and obese.(7) CME available online at www.”
BackgroundObesity and Cardiovascular Disease
Ortega, F. B., Lavie, C. J., & Blair, S. N. (2016) · Circulation Research · doi:10.1161/circresaha.115.306883 · Cited by 1,202
Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease
Meigs, J. B., Wilson, P. W. F., Fox, C. S., Vasan, R. S., Nathan, D. M., Sullivan, L. M., & D’Agostino, R. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0594 · Cited by 1,062
Identification and characterization of metabolically benign obesity in humans
Stefan, N. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1609 · Cited by 1,049
Kahn, H. S. (2005) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-5-26 · Cited by 968
Metabolically healthy obesity: Epidemiology, mechanisms, and clinical implications
Stefan, N., Häring, H.-U., Hu, F. B., & Schulze, M. B. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70062-7 · Cited by 857
Characterizing the profile of obese patients who are metabolically healthy
Primeau, V, Coderre, L., Karelis, A. D., Brochu, M., Lavoie, M.-E., Messier, V, Sladek, R., & Rabasa-Lhoret, R. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.216 · Cited by 637
Self-citationPower, M. L., & Schulkin, J. (2008) · British Journal of Nutrition · doi:10.1017/s0007114507853347 · Cited by 605
The Concept of Normal Weight Obesity
Oliveros, E., Somers, V. K., Sochor, O., Goel, K., & Lopez-Jimenez, F. (2014) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2013.10.003 · Cited by 601
Adipogenesis and WNT signalling
Christodoulides, C., Lagathu, C., Sethi, J. K., & Vidal-Puig, A. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.09.002 · Cited by 598
The metabolically healthy but obese individual presents a favorable inflammation profile
Karelis, A. D., Faraj, M., Bastard, J.-P., St-Pierre, D. H., Brochu, M., Prud’homme, D., & Rabasa-Lhoret, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0482 · Cited by 579
Self-citationCauses, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans
Stefan, N., Schick, F., & Häring, H.-U. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.008 · Cited by 575
Causes, consequences, and treatment of metabolically unhealthy fat distribution
Stefan, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30110-8 · Cited by 541
Bays, H. E., González-Campoy, J. M., Bray, G. A., Kitabchi, A. E., Bergman, D. A., Schorr, A. B., Rodbard, H. W., & Henry, R. R. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.343 · Cited by 530
Ortega, F. B., Lee, D.-C., Katzmarzyk, P. T., Ruiz, J. R., Sui, X., Church, T. S., & Blair, S. N. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs174 · Cited by 468
Bays, H. E. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.038 · Cited by 431
Speiser, P. W., Rudolf, M. C. J., Anhalt, H., Camacho-Hubner, C., Chiarelli, F., Eliakim, A., Freemark, M., Gruters, A., Hershkovitz, E., Iughetti, L., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1389 · Cited by 415
Metabolic Syndrome, Obesity, and Mortality
Katzmarzyk, P. T., Church, T. S., Janssen, I., Ross, R., & Blair, S. N. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.391 · Cited by 378
Association of Muscular Strength with Incidence of Metabolic Syndrome in Men
JURCA, R., LAMONTE, M. J., BARLOW, C. E., KAMPERT, J. B., CHURCH, T. S., & BLAIR, S. N. (2005) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000175865.17614.74 · Cited by 371
Hinnouho, G.-M., Czernichow, S., Dugravot, A., Nabi, H., Brunner, E. J., Kivimaki, M., & Singh-Manoux, A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu123 · Cited by 366
Swainson, M. G., Batterham, A. M., Tsakirides, C., Rutherford, Z. H., & Hind, K. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177175 · Cited by 344
Kim, D., & Kim, W. R. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.08.028 · Cited by 341
Impact of Mediterranean diet on metabolic syndrome, cancer and longevity
Di Daniele, N., Noce, A., Vidiri, M. F., Moriconi, E., Marrone, G., Annicchiarico-Petruzzelli, M., D’Urso, G., Tesauro, M., Rovella, V., & De Lorenzo, A. (2017) · Oncotarget · doi:10.18632/oncotarget.13553 · Cited by 324
Carmina, E., Bucchieri, S., Esposito, A., Del Puente, A., Mansueto, P., Orio, F., Di Fede, G., & Rini, G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2725 · Cited by 317
“On the other hand, it has been reported that at least 80% of obese subjects are affected by abdominal obesity (11, 12).”
BackgroundMetabolically healthy obesity: the low-hanging fruit in obesity treatment?
Stefan, N., Häring, H.-U., & Schulze, M. B. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30292-9 · Cited by 309
New obesity classification criteria as a tool for bariatric surgery indication
Lorenzo, A. D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.681 · Cited by 306
Zhang, M., Wang, B., Liu, Y., Sun, X., Luo, X., Wang, C., Li, L., Zhang, L., Ren, Y., Zhao, Y., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0514-x · Cited by 305
Role of quercetin as an alternative for obesity treatment: You are what you eat!
Nabavi, S. F., Russo, G. L., Daglia, M., & Nabavi, S. M. (2015) · Food Chemistry · doi:10.1016/j.foodchem.2015.02.006 · Cited by 304
Freedland, E. S. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-12 · Cited by 298
A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese
Xia, M.-F., Chen, Y., Lin, H.-D., Ma, H., Li, X.-M., Aleteng, Q., Li, Q., Wang, D., Hu, Y., Pan, B.-S., et al. (2016) · Scientific Reports · doi:10.1038/srep38214 · Cited by 292
The renin‐angiotensin system: a link between obesity, inflammation and insulin resistance
Kalupahana, N. S., & Moustaid‐Moussa, N. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00942.x · Cited by 276
Metabolically healthy but obese individuals
Karelis, A. D. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61531-7 · Cited by 269
Self-citationCan we identify metabolically healthy but obese individuals (MHO)?
Karelis, A., Brochu, M., & Rabasa-Lhoret, R. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70156-8 · Cited by 269
Self-citationAung, K., Lorenzo, C., Hinojosa, M. A., & Haffner, S. M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2832 · Cited by 266
Normal-weight obese syndrome: early inflammation?
De Lorenzo, A., Del Gobbo, V., Premrov, M. G., Bigioni, M., Galvano, F., & Di Renzo, L. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.1.40 · Cited by 263
Normal weight obese (NWO) women: An evaluation of a candidate new syndrome
De Lorenzo, A., Martinoli, R., Vaia, F., & Di Renzo, L. (2006) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.10.010 · Cited by 261
Phenotypes of prediabetes and stratification of cardiometabolic risk
Stefan, N., Fritsche, A., Schick, F., & Häring, H.-U. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00082-6 · Cited by 208
Elffers, T. W., de Mutsert, R., Lamb, H. J., de Roos, A., Willems van Dijk, K., Rosendaal, F. R., Jukema, J. W., & Trompet, S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0185403 · Cited by 167
Succurro, E., Marini, M. A., Frontoni, S., Hribal, M. L., Andreozzi, F., Lauro, R., Perticone, F., & Sesti, G. (2008) · Obesity · doi:10.1038/oby.2008.308 · Cited by 158
Effect of Sarcopenia on Cardiovascular Disease Risk Factors in Obese Postmenopausal Women
Aubertin‐Leheudre, M., Lord, C., Goulet, É. D. B., Khalil, A., & Dionne, I. J. (2006) · Obesity · doi:10.1038/oby.2006.267 · Cited by 151
Adipose tissue gene expression of factors related to lipid processing in obesity
Clemente-Postigo, M., Queipo-Ortuño, M. I., Fernandez-Garcia, D., Gomez-Huelgas, R., Tinahones, F. J., & Cardona, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024783 · Cited by 124
“It has been proposed that the expansion capacity of the adipose tissue rather than the adipose tissue size could be, at least in part, responsible for these inter-individual differences [3], and fat accumulation in the visceral adipose tissue (VAT) is a higher risk factor for the development of clinical complications…”
Healthy eating index and metabolically healthy obesity in U.S. adolescents and adults
Camhi, S. M., Whitney Evans, E., Hayman, L. L., Lichtenstein, A. H., & Must, A. (2015) · Preventive Medicine · doi:10.1016/j.ypmed.2015.04.023 · Cited by 111
“, 2003), however, not all obese individuals exhibit this cardiometabolic phenotype (Karelis et al., 2004; Sims, 2001).”
BackgroundTinahones, F. J., Coín-Aragüez, L., Mayas, M. D., Garcia-Fuentes, E., Hurtado-del-Pozo, C., Vendrell, J., Cardona, F., Calvo, R.-M., Obregon, M.-J., & El Bekay, R. (2012) · BMC Physiology · doi:10.1186/1472-6793-12-4 · Cited by 95
Obesity associated disease risk: the role of inherent differences and location of adipose depots
Hill, J. H., Solt, C., & Foster, M. T. (2018) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2018-0012 · Cited by 79
Bays, H. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.125 · Cited by 66
Su, P.-Y., Hsu, Y.-C., Cheng, Y.-F., Kor, C.-T., & Su, W.-W. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-1032-y · Cited by 49
Avolio, E., Gualtieri, P., Romano, L., Pecorella, C., Ferraro, S., Palma, G., Di Renzo, L., & De Lorenzo, A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867326666190326113607 · Cited by 43
Lorcaserin and adiposopathy: 5-HT2c agonism as a treatment for 'sick fat' and metabolic disease
Bays, H. E. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.123 · Cited by 39
Donini, L., Merola, G., Poggiogalle, E., Lubrano, C., Gnessi, L., Mariani, S., Migliaccio, S., & Lenzi, A. (2016) · Nutrients · doi:10.3390/nu8120759 · Cited by 32
Metadata
- Authors
- Karelis, A. D., St-Pierre, D. H., Conus, F., Rabasa-Lhoret, R., & Poehlman, E. T.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-06-01
- Volume
- 89
- Issue
- 6
- Pages
- 2569-2575
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2048717385
- Cited by
- 723
- References
- 40
- FWCI
- 15.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.